Latest Breaking News On - Praxis precision medicines - Page 1 : comparemela.com

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DLD Asset Management LP Acquires New Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)

DLD Asset Management LP acquired a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,000 shares of the company’s stock, valued at approximately $223,000. DLD Asset Management LP owned about […]

Praxis Precision Medicines (NASDAQ:PRAX): A Wild Rollercoaster Ride

Bringing an experimental treatment or drug to the market can be a wild rollercoaster ride. Take Praxis Precision Medicines (NASDAQ:PRAX) as a case .

Praxis Precision Medicines (NASDAQ:PRAX) Given Buy Rating at Truist Financial

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Truist Financial in a report released on Thursday, Benzinga reports. They currently have a $150.00 target price on the stock. Truist Financial’s target price suggests a potential upside of 233.70% from the stock’s current price. PRAX has been […]

Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright